Literature DB >> 32151057

Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.

Raynoo Thanan1,2, Waleeporn Kaewlert1,2, Chadamas Sakonsinsiri1,2, Timpika Chaiprasert1,2, Napat Armartmuntree1,2, Duangkamon Muengsaen1,2, Anchalee Techasen2,3, Poramate Klanrit1,2, Worachart Lert-Itthiporn1, Somchai Pinlaor2,4, Chawalit Pairojkul5.   

Abstract

Cholangiocarcinoma (CCA), a malignancy of biliary epithelium, is related to liver stem cell deregulation. FoxAs are a group of transcription factors that play critical roles in liver stem cell differentiation. In this study, the expression levels of FoxAs (i.e., FoxA1, FoxA2 and FoxA3) were detected in intrahepatic CCA tissues and the functions of FoxAs were studied in CCA cell lines. FoxA1 and FoxA2 were mainly localized in the nuclei of normal bile duct (NBD) cells and some of the cancer cells. Low expression of FoxA1 in CCA tissues (72%) was significantly correlated with poor prognosis. FoxA3 expression of CCA cells was localized in the nucleus and cytoplasm, whereas it was slightly detected in NBDs. High expression of FoxA3 in cancer tissues (61%) was significantly related to high metastasis status. These findings suggest the opposing roles of FoxA1 and FoxA3 in CCA. Moreover, the FoxA1-over-expressing CCA cell line exhibited a significant reduction in proliferative and invasive activities compared to control cells. Knockdown of FoxA3 in CCA cells resulted in a significant decrease in proliferative and invasive activities compared with control cells. Taken together, in CCA, FoxA1 is down-regulated and has tumor suppressive roles, whereas FoxA3 is up-regulated and has oncogenic roles.

Entities:  

Keywords:  FoxA1; FoxA2; FoxA3; FoxAs; cancer; cholangiocarcinoma

Year:  2020        PMID: 32151057     DOI: 10.3390/ijms21051796

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  5 in total

1.  Systematic Investigations on the Metabolic and Transcriptomic Regulation of Lactate in the Human Colon Epithelial Cells.

Authors:  Chongyang Huang; Huanzhou Xu; Xin Zhou; Maili Liu; Jing Li; Chaoyang Liu
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

2.  ARID1A alterations and their clinical significance in cholangiocarcinoma.

Authors:  Achira Namjan; Anchalee Techasen; Watcharin Loilome; Prakasit Sa-Ngaimwibool; Apinya Jusakul
Journal:  PeerJ       Date:  2020-12-03       Impact factor: 2.984

3.  Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.

Authors:  Pirawan Poosekeaw; Chawalit Pairojkul; Banchob Sripa; Prakasit Sa Ngiamwibool; Sitthichai Iamsaard; Chadamas Sakonsinsiri; Raynoo Thanan; Piti Ungarreevittaya
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

4.  Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.

Authors:  Guangzhen Ma; Jirong Chen; Tiantian Wei; Jia Wang; Wenshan Chen
Journal:  Cytotechnology       Date:  2021-05-26       Impact factor: 2.040

5.  High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.

Authors:  Heba Sheta; Amal Abd El Hafez; Maha Saif; Alyaa R Elsergany; Doaa Al Emam; Mahmoud Mohamed Abdelrazik
Journal:  Pathologica       Date:  2021-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.